Skip to main content
Clinical Trials/DRKS00008765
DRKS00008765
Completed
未知

Dopaminergic and cholinergic modulation of oculomotor control during saccades

Translational Neuromodeling Unit, Institut für Biomedizinische Technik, Universität Zürich und ETH Zürich0 sites150 target enrollmentJune 11, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy participants
Sponsor
Translational Neuromodeling Unit, Institut für Biomedizinische Technik, Universität Zürich und ETH Zürich
Enrollment
150
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 11, 2015
End Date
June 30, 2017
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Translational Neuromodeling Unit, Institut für Biomedizinische Technik, Universität Zürich und ETH Zürich

Eligibility Criteria

Inclusion Criteria

  • Age: \=18 and \=40 years
  • European ancestry
  • Written informed consent
  • Consent to adhere to the study protocol
  • Ability to adhere to the study protocol

Exclusion Criteria

  • Serious past or present brain disease, brain injury or brain surgery
  • Any neurological or psychiatric disorders (past or present)
  • Current psychoactive medication
  • Daily nicotin use
  • Daily alcohol use \> 2 units per day on average (1 unit \= 3 dl beer \= 1 dl wine)
  • Current use of recreational drugs
  • History of drug abuse
  • Any current severe medical condition
  • Additional exclusion criteria for the pharmacological study branches:
  • Tachy\- or bradycardia (normal range 55\-100 bpm), cardiac arrhythmia and/or QTc\-time \>430 ms

Outcomes

Primary Outcomes

Not specified

Similar Trials